These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19666215)

  • 61. Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia.
    de Haan L; Nimwegen Lv; Amelsvoort Tv; Dingemans P; Linszen D
    Pharmacopsychiatry; 2008 Jul; 41(4):125-8. PubMed ID: 18651339
    [TBL] [Abstract][Full Text] [Related]  

  • 62. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study.
    Chang WC; Hui CL; Tang JY; Wong GH; Lam MM; Chan SK; Chen EY
    Schizophr Res; 2011 Dec; 133(1-3):22-8. PubMed ID: 21968080
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients.
    Jäger M; Riedel M; Obermeier M; Schennach-Wolff R; Seemüller F; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Bottlender R; Möller HJ
    Schizophr Res; 2010 May; 118(1-3):183-8. PubMed ID: 20181461
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
    Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: an analysis of the CATIE Schizophrenia Trial.
    Glick HA; Li P; Harvey PD
    Schizophr Res; 2015 Aug; 166(1-3):110-4. PubMed ID: 26044113
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Remission in schizophrenia: applying recent consensus criteria to refine the concept.
    Lasser RA; Nasrallah H; Helldin L; Peuskens J; Kane J; Docherty J; Tronco AT
    Schizophr Res; 2007 Nov; 96(1-3):223-31. PubMed ID: 17765480
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
    Fond G; Godin O; Schürhoff F; Berna F; André M; Aouizerate B; Capdevielle D; Chereau I; D' Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Szoke A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109927. PubMed ID: 32173456
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Validation of a four items version of the Functional Remission of General Schizophrenia scale (the mini-FROGS) to capture the functional benefits of clinical remission.
    Mallet J; Lancrenon S; Llorca PM; Lançon C; Baylé FJ; Gorwood P
    Eur Psychiatry; 2018 Jan; 47():35-41. PubMed ID: 29100170
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Severity of core symptoms in first episode schizophrenia and long-term remission.
    Marchesi C; Affaticati A; Monici A; De Panfilis C; Ossola P; Tonna M
    Psychiatry Res; 2015 Jan; 225(1-2):129-132. PubMed ID: 25467699
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The assessment of quality of life in clinical practice in patients with schizophrenia.
    Karow A; Wittmann L; Schöttle D; Schäfer I; Lambert M
    Dialogues Clin Neurosci; 2014 Jun; 16(2):185-95. PubMed ID: 25152657
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Symptomatic remission in a multiracial urban population of older adults with schizophrenia.
    Bankole A; Cohen CI; Vahia I; Diwan S; Palekar N; Reyes P; Sapra M; Ramirez PM
    Am J Geriatr Psychiatry; 2008 Dec; 16(12):966-73. PubMed ID: 19038895
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Symptomatic remission and associated factors in a catchment area based population of older patients with schizophrenia.
    Meesters PD; Comijs HC; de Haan L; Smit JH; Eikelenboom P; Beekman AT; Stek ML
    Schizophr Res; 2011 Mar; 126(1-3):237-44. PubMed ID: 20888190
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Remission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient population.
    Mosolov SN; Potapov AV; Ushakov UV
    Ann Gen Psychiatry; 2012 Jan; 11(1):1. PubMed ID: 22221826
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Association of Social Support and Symptomatic Remission among Community-Dwelling Schizophrenia Patients: A Cross-Sectional Study.
    Fan CH; Hsu SC; Hsiao FH; Chang CM; Liu CY; Lai YM; Chen YT
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33918873
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later.
    Lambert M; Karow A; Leucht S; Schimmelmann BG; Naber D
    Dialogues Clin Neurosci; 2010; 12(3):393-407. PubMed ID: 20954433
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods.
    Schennach R; Möller HJ; Obermeier M; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Musil R; Spellmann I; Riedel M
    Int J Methods Psychiatr Res; 2016 Mar; 25(1):3-11. PubMed ID: 26178421
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A question of time: A study of time use in people with schizophrenia.
    Cella M; Edwards C; Wykes T
    Schizophr Res; 2016 Oct; 176(2-3):480-484. PubMed ID: 27422333
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recovery from schizophrenia: is it possible?
    Vita A; Barlati S
    Curr Opin Psychiatry; 2018 May; 31(3):246-255. PubMed ID: 29474266
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The complex relationship between self-reported 'personal recovery' and clinical recovery in schizophrenia.
    Rossi A; Amore M; Galderisi S; Rocca P; Bertolino A; Aguglia E; Amodeo G; Bellomo A; Bucci P; Buzzanca A; Carpiniello B; Comparelli A; Dell'Osso L; di Giannantonio M; Mancini M; Marchesi C; Monteleone P; Montemagni C; Oldani L; Roncone R; Siracusano A; Stratta P; Tenconi E; Vignapiano A; Vita A; Zeppegno P; Maj M;
    Schizophr Res; 2018 Feb; 192():108-112. PubMed ID: 28495492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.